Skip to main content

Table 2 Bioassays for PD-L1 expression

From: Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy

Antibodies Bioassays
Pembrolizumab Dako 22C3
Nivolumab Dako 28-8
Atezolizumab Ventana SP142
Durvalumab Ventana SP263
Avelumab NA
  1. NA not applicable